{"groundTruth": ["齐头并进"], "candidates": [["三足鼎立", "一马当先", "齐头并进", "油腔滑调", "生死与共", "所向披靡", "物尽其用"]], "content": "伊立替康注射液通过美国FDA首次检查，继续推进多西他赛、来曲唑、奥沙利铂等优势品种FDA制剂和原料药出口公司去年开始改革研发体系，创新药、仿制药和生物药研发#idiom#；销售体系将根据产品线和科室区分，开展调整和转型。", "realCount": 1}